Osilodrostat Phosphate Patent Expiration
Osilodrostat Phosphate is used for treating Cushing's disease. It was first introduced by Recordati Rare Diseases Inc
Osilodrostat Phosphate Patents
Given below is the list of patents protecting Osilodrostat Phosphate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Isturisa | US10709691 | Pharmaceutical dosage forms | Oct 12, 2035 | Recordati Rare |
| Isturisa | US10143680 | Pharmaceutical dosage forms | Jul 06, 2035 | Recordati Rare |
| Isturisa | US8609862 | Use of an adrenal hormone-modifying agent | Jan 13, 2031 | Recordati Rare |
| Isturisa | US9434754 | Use of an adrenal hormone-modifying agent | Jan 13, 2031 | Recordati Rare |
| Isturisa | US8314097 | Organic compounds | Mar 27, 2029 | Recordati Rare |
| Isturisa | US8835646 | Organic compounds | Aug 23, 2026 | Recordati Rare |
Osilodrostat Phosphate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List